The quality of life of patients with genital warts: a qualitative study
- PMID: 20205944
- PMCID: PMC2848198
- DOI: 10.1186/1471-2458-10-113
The quality of life of patients with genital warts: a qualitative study
Abstract
Background: Genital warts, which are caused by infection with human papillomavirus (HPV), are one of the most common sexually transmitted diseases in Europe. Although genital warts are commonly perceived as a non-serious condition, treatment is often long, of varying effectiveness and the recurrence rate is high. Very few studies have been performed on the personal consequences of genital warts. The aim of this qualitative study, set in Denmark, was to examine the ways in which genital warts may affect patients' quality of life.
Methods: To obtain an in-depth understanding of patients' perceptions of genital warts, we used qualitative focus-group interviews with five men and five women aged between 18 and 30 years who had genital warts. The interview guide was based on a literature review that identified important issues and questions. The data were analysed using a medical anthropological approach.
Results: Patients' experiences were related to cultural conceptions of venereal diseases and the respective identities and sexuality of the sexes. The disease had negative psychological and social effects both for men and for women and it affected their sex and love lives, in particular. The psychological burden of the disease was increased by the uncertain timeline and the varying effectiveness of treatment. We identified a need for more patient information about the disease and its psycho-sexual aspects.
Conclusions: The men and women participating in this study considered their quality of life to be significantly lowered because of genital warts. The experiences described by the participants give insights that may be valuable in treatment and counselling.The quadrivalent HPV vaccine that has now been added to the childhood vaccination programme for girls in Denmark for the prevention of cervical cancer can also prevent 90% of cases of genital warts. Our results suggest that HPV vaccination could considerably reduce the largely unacknowledged psychological and social burden associated with genital warts, in men as well as women.
Figures
Similar articles
-
[Quality of life of patients with condyloma].Ugeskr Laeger. 2008 Nov 17;170(47):3858-62. Ugeskr Laeger. 2008. PMID: 19014739 Danish.
-
Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.Lancet Infect Dis. 2022 Mar;22(3):413-425. doi: 10.1016/S1473-3099(21)00327-3. Epub 2021 Nov 12. Lancet Infect Dis. 2022. PMID: 34780705 Clinical Trial.
-
Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.Lancet Infect Dis. 2011 Jan;11(1):39-44. doi: 10.1016/S1473-3099(10)70225-5. Epub 2010 Nov 8. Lancet Infect Dis. 2011. PMID: 21067976
-
Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.BioDrugs. 2011 Oct 1;25(5):339-43. doi: 10.2165/11205060-000000000-00000. BioDrugs. 2011. PMID: 21942919 Review.
-
Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women.Drugs. 2010 Dec 24;70(18):2449-74. doi: 10.2165/11204920-000000000-00000. Drugs. 2010. PMID: 21142263 Review.
Cited by
-
Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents.BMC Public Health. 2015 Dec 18;15:1257. doi: 10.1186/s12889-015-2579-3. BMC Public Health. 2015. PMID: 26684658 Free PMC article.
-
Serological test results of sexually transmitted diseases in patients with condyloma acuminata.Postepy Dermatol Alergol. 2015 Aug;32(4):286-9. doi: 10.5114/pdia.2015.48065. Epub 2015 Aug 12. Postepy Dermatol Alergol. 2015. PMID: 26366153 Free PMC article.
-
Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review.Cancers (Basel). 2024 Feb 5;16(3):672. doi: 10.3390/cancers16030672. Cancers (Basel). 2024. PMID: 38339423 Free PMC article. Review.
-
HPV-related information sharing and factors associated with U.S. men's disclosure of an HPV test result to their female sexual partners.Sex Transm Infect. 2012 Apr;88(3):171-6. doi: 10.1136/sextrans-2011-050091. Epub 2012 Jan 3. Sex Transm Infect. 2012. PMID: 22215695 Free PMC article.
-
Clinical and Public Health Considerations for HPV Vaccination in Midadulthood: A Narrative Review.Open Forum Infect Dis. 2023 Jan 11;10(1):ofad004. doi: 10.1093/ofid/ofad004. eCollection 2023 Jan. Open Forum Infect Dis. 2023. PMID: 36726535 Free PMC article. Review.
References
-
- Smith E, Poulsen S. Indstilling vedr. Indførelse af humant papillomvirus (HPV) vaccination i Det Danske Børnevaccinationsprogram. [Introduction of human papillomavirus (HPV) vaccination into the Danish Childhood Immunisation Programme] The National Board of Health. 2007.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical